Paul L Crispen, MD - Research

Research at a glance

Top areas of exploration

Kidney Neoplasms , 39 publications
Carcinoma, Renal Cell , 28 publications
Nephrectomy , 20 publications
Prostatic Neoplasms , 16 publications

Research activity

95 publications

4,527 citations

Why is this important?

Active clinical trials

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Bladder cancer is the 8th most common cancer in the 网红黑料 Cancer Center catchment area and the 7th most common cancer presenting to UF网红黑料. Most newly diagnosed cases are stage I bladder cancer, which is defined by having no deep muscle鈥�

Investigator: Paul L Crispen
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC

This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not respond to Bacillus Calmette-Guerin (BCG) treatment. Chemotherapy drugs, such as鈥�

Investigator: Paul L Crispen
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

95 publications

2009

Radiation therapy after radical prostatectomy: impact on metastasis and survival.

The Journal of urology

鈥�

2009

T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

Urology

鈥�

2009

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

The Journal of urology

鈥�

2008

Delayed intervention of sporadic renal masses undergoing active surveillance.

Cancer

鈥�

2008

Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.

The Prostate

鈥�

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Radiation therapy after radical prostatectomy: impact on metastasis and survival.

T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis.

The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy.

Delayed intervention of sporadic renal masses undergoing active surveillance.

Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway.